These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
307 related articles for article (PubMed ID: 25987446)
41. Hopes build that new infrastructure can aid drug discovery. Esteves B Nat Med; 2011 Oct; 17(10):1174-5. PubMed ID: 21988981 [No Abstract] [Full Text] [Related]
42. Affairs of the Heart: Innovation in Cardiovascular Research and Development. Honig P; Terzic A Clin Pharmacol Ther; 2017 Aug; 102(2):162-168. PubMed ID: 28718903 [TBL] [Abstract][Full Text] [Related]
43. The future of discovery chemistry: quo vadis? Academic to industrial--the maturation of medicinal chemistry to chemical biology. Hoffmann T; Bishop C Drug Discov Today; 2010 Apr; 15(7-8):260-4. PubMed ID: 20149893 [TBL] [Abstract][Full Text] [Related]
44. Market watch: Biopharma deal-making in 2014: a record year for M&A value. Micklus A; Muntner S Nat Rev Drug Discov; 2015 Feb; 14(2):84-5. PubMed ID: 25633786 [No Abstract] [Full Text] [Related]
45. Translational research in academia and industry. Clackson T Exp Biol Med (Maywood); 2006 Dec; 231(11):1685-9. PubMed ID: 17138754 [TBL] [Abstract][Full Text] [Related]
46. Opportunities and challenges in the discovery of new central nervous system drugs. Krause JE; Chenard BL Ann N Y Acad Sci; 2008 Nov; 1144():243-50. PubMed ID: 19076381 [TBL] [Abstract][Full Text] [Related]
48. Advancing the drug discovery and development process. Nicolaou KC Angew Chem Int Ed Engl; 2014 Aug; 53(35):9128-40. PubMed ID: 25045053 [TBL] [Abstract][Full Text] [Related]
49. Drug discovery in academia. Shamas-Din A; Schimmer AD Exp Hematol; 2015 Aug; 43(8):713-7. PubMed ID: 25912018 [TBL] [Abstract][Full Text] [Related]
50. Chemistry strategies in early drug discovery: an overview of recent trends. Colombo M; Peretto I Drug Discov Today; 2008 Aug; 13(15-16):677-84. PubMed ID: 18675762 [TBL] [Abstract][Full Text] [Related]
51. The inadequacy of the reductionist approach in discovering new therapeutic agents against complex diseases. Duval MX Exp Biol Med (Maywood); 2018 Aug; 243(12):1004-1013. PubMed ID: 30089398 [TBL] [Abstract][Full Text] [Related]
52. Grants4Targets: an open innovation initiative to foster drug discovery collaborations. Dorsch H; Jurock AE; Schoepe S; Lessl M; Asadullah K Nat Rev Drug Discov; 2015 Jan; 14(1):74-6. PubMed ID: 25430867 [No Abstract] [Full Text] [Related]
53. Discovery research: the scientific challenge of finding new antibiotics. Livermore DM; J Antimicrob Chemother; 2011 Sep; 66(9):1941-4. PubMed ID: 21700626 [TBL] [Abstract][Full Text] [Related]
54. Menelas Pangalos. Interview by Asher Mullard. Mullard A Nat Rev Drug Discov; 2013 Jun; 12(6):418. PubMed ID: 23722338 [No Abstract] [Full Text] [Related]
55. The new biology. Genomics fosters a "systems approach" and collaborations between academic, government, and industry scientists. Eckardt NA Plant Cell; 2001 Apr; 13(4):725-32. PubMed ID: 11283331 [No Abstract] [Full Text] [Related]
56. Drug discovery goes back to school: changing ecosystem of drug discovery and the rising role of academia. Slusher B J Peripher Nerv Syst; 2014 Oct; 19 Suppl 2():S2-4. PubMed ID: 25269734 [No Abstract] [Full Text] [Related]
57. Open innovation: share or die.. Talaga P Drug Discov Today; 2009 Nov; 14(21-22):1003-5. PubMed ID: 19778629 [No Abstract] [Full Text] [Related]
58. Discontinued drugs in 2010: oncology drugs. Williams R Expert Opin Investig Drugs; 2011 Nov; 20(11):1479-96. PubMed ID: 21955127 [TBL] [Abstract][Full Text] [Related]